Resmed Inc. buy KeyCorp
Start price
30.01.26
/
50%
€222.50
Target price
30.01.27
-
Performance (%)
-12.65%
Price
02.04.26
€194.35
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.65%. This prediction currently runs until 30.01.27. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.541% | 1.541% |
| iShares Core DAX® | 4.852% | -2.747% |
| iShares Nasdaq 100 | 3.999% | -3.330% |
| iShares Nikkei 225® | 4.221% | -2.912% |
| iShares S&P 500 | 3.324% | -2.954% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "overweight" rating reaffirmed by analysts at KeyCorp.
Ratings data for RMD provided by MarketBeat